Instead, we present evidence that the basis of this enhanced anti-leukemia activity is via relief of an unexpected repressive effect of BRD4 on expression of p53 target genes, thereby unleashing the full pro-apoptotic activity of p53 stabilized by MDM2i. This evidence concerns the gene TP53 and leukemia.